Type 2 Diabetes Mellitus Completed Phase 1 Trials for Glucagon (DB00040)

Also known as: Non-Insulin-Dependent Diabetes Mellitus / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes / Diabetes, Type II / Type II Diabetes Mellitus / T2DM / Type Two Diabetes Mellitus / Diabetes mellitus non-insulin-dependent / NIDDM / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / Diabetes Mellitus, Type 2 / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

DBCOND0029752 (Type 2 Diabetes Mellitus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00817271To Evaluate the Response to Glucagon During HypoglycemiaTreatment
NCT01300260Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseTreatment
NCT02806973A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesBasic Science
NCT03444467First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.Treatment
NCT00823940A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal SubjectsTreatment
NCT02012166A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)Treatment
NCT03350191A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsBasic Science